Data on Cabozantinib Activity in Brain Metastases in RCC
Results from a retrospective analysis evaluating (cabozantinib) activity in brain metastases in patients with renal cell carcinoma (RCC) will be presented as part of the Poster Session: Renal Cell Cancer at the 2021 American...
Read More